NRXS
#4094
Neuraxis, Inc. Common Stock
5.9 7 USD
-0.01%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-1.32%
Monthly Change
-0.67%
6 month change
+1.62%
Year Change
+9.94%
Previous Close
6.0 5
Open
5.9 9
Low
5.9 6
High
6.0 0
Volume
14
Financials
- Market Capitalization 74.97 M
- Employee 24
- Founded 2011
- CEO N/A
- Website www.neuraxis.com
- Headquarter Delaware, United States
- FIGI BBG01C9N12C3
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-4.78
Price to sales ratio
11.55
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4089 |  LONA LeonaBio, Inc. - Common Stock | 8.00 USD | +1.39% | +5.68% | +9.29% | +18.69% | 75.37 M USD | ||
| 4090 |  RNXT RenovoRx, Inc. - Common Stock | 1.67 USD | +12.84% | +25.56% | +75.79% | +73.96% | 75.37 M USD | ||
| 4096 |  ELTX Elicio Therapeutics, Inc. - Common Stock | 2.84 USD | -5.33% | -7.19% | -4.05% | -71.60% | 74.64 M USD | ||
| 4106 |  ANVS Annovis Bio, Inc. Common Stock | 1.72 USD | -4.97% | -6.01% | -2.82% | -25.54% | 73.28 M USD |
Frequently asked questions about Neuraxis, Inc.
What is the Neuraxis, Inc. stock price today?
The current price of Neuraxis, Inc. (NRXS) is 5.97. Over the past 24 hours, the stock has changed by -1.32%. Follow the NRXS chart for real-time price dynamics.
What is the stock ticker of Neuraxis, Inc.?
Neuraxis, Inc. trades under the ticker NRXS. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Neuraxis, Inc. stock going up?
NRXS has changed by -3.24% over the last week, -0.67% over the last month, and +9.94% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Neuraxis, Inc.?
Neuraxis, Inc. currently has a market capitalization of 74.97 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Neuraxis, Inc. earnings last quarter?
Last quarter, Neuraxis, Inc. reported earnings of -0.19 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Neuraxis, Inc. revenue for the last quarter?
Neuraxis, Inc. reported quarterly revenue of 1.93 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Neuraxis, Inc. net income for the last quarter?
Neuraxis, Inc. reported net income of -2.09 M for the last quarter. The previous quarter showed -1.76 M, which means net income changed by -18.41%.
How many employees does Neuraxis, Inc. have?
As of the latest available data, Neuraxis, Inc. has 24 employees. Workforce size can provide additional context about the company's scale and operations.
What is Neuraxis, Inc. EBITDA?
Neuraxis, Inc. EBITDA is -1.02 M, and its EBITDA margin is -52.78%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Neuraxis, Inc. stock?
You can buy Neuraxis, Inc. (NRXS) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Neuraxis, Inc. stock?
Investing in Neuraxis, Inc. requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the NRXS chart and related analysis on metatrader.com as part of your research.